Sonja Eilts
YOU?
Author Swipe
View article: Assessment of Retinopathy of Prematurity Regression and Reactivation Using an Artificial Intelligence–Based Vascular Severity Score
Assessment of Retinopathy of Prematurity Regression and Reactivation Using an Artificial Intelligence–Based Vascular Severity Score Open
Importance One of the biggest challenges when using anti–vascular endothelial growth factor (VEGF) agents to treat retinopathy of prematurity (ROP) is the need to perform long-term follow-up examinations to identify eyes at risk of ROP rea…
View article: Anti‐drug antibodies to brolucizumab and ranibizumab in serum and vitreous of patients with ocular disease
Anti‐drug antibodies to brolucizumab and ranibizumab in serum and vitreous of patients with ocular disease Open
Purpose Postapproval reports of intraocular inflammation (IOI) and occlusive retinal vasculitis following intravitreal brolucizumab are accumulating. A role of anti‐drug antibodies (ADAs) to brolucizumab is under current scientific discuss…